biotechnology
Sudden Outbreak & Spread of COVID-19 Driving Market Growth
The global coronavirus outbreak wreaked havoc on the supply chain. Lockdowns were imposed to stop the virus from spreading, resulting in local borders, reduced air travel, and a trade prohibition. Furthermore, due to the shutdown of several industries, there were several challenges with the supply of consumables, reagents, and instruments required in optical genome mapping. All of this resulted in a shortage of consumables, reagents, and instruments in some nations and hoarding in countries that manufacture these items. Furthermore, since academic and research institutes were either shut down or concentrated on creating a therapy for new coronavirus, there was an interruption in research and development efforts linked to optical genome mapping. On the other hand, the biotechnology and pharmaceutical industries were equally committed to finding a cure for novel coronavirus.
Increasing Awareness for Prenatal Testing Supporting Market Growth
The need for procedures like optical genome mapping has expanded as the public's understanding of prenatal testing has grown. Optical genome mapping (OGM) is a novel technology that outperforms existing methods by detecting all sorts of structural variants (SVs), including copy number variations (CNVs). Laboratories utilize the method to diagnose hematological malignancies and prenatal and postnatal constitutional genetic disorders. The use of this technology in prenatal testing and the diagnosis of various genetic abnormalities has been demonstrated in studies. This, in turn, is likely to fuel market expansion.
Growing Demand of
Inefficiency of Next Generation Sequencing Supporting Market Growth of Optical Genome Mapping Market
Next-Generation Sequencing
Click here to download the sample
Market Segmentation
United States optical genome mapping market stood at USD38.95 million in 2021
Company Profiles
Bionano Genomics, Inc., Nabsys Inc, Nucleome Informatics Pvt Ltd, France Génomique, Praxis Genomics LLC, PerkinElmer, Inc., OpGen, Inc., are among the major market players operating in the global optical genome mapping market.
Attribute | Details |
Market size value in 2021 | USD101.11 Million |
Revenue Forecast in 2027 | USD288.33 Million |
United States Market Size Value in 2021 | USD38.95 Million |
Growth Rate | 19.73% |
Base Year | 2021 |
Historical Years | 2017 – 2020 |
Estimated Year | 2022 |
Forecast Period | 2023 – 2027 |
Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | · Product · Application · End User |
Regional Scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country Scope | United States; Canada; Mexico; France; United Kingdom; Germany; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE; |
Key Companies Profiled | Bionano Genomics, Inc., Nabsys Inc, Nucleome Informatics Pvt Ltd, France Génomique, Praxis Genomics LLC, PerkinElmer, Inc., OpGen, Inc |
Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/pdf format on special request) |